Protective Effects of AR1001 in Alzheimer's Disease Models...
It is suggested that the multimodal activity of AR1001 contributes to the therapeutic effects of AR1001 observed in the phase 2 clinical trial in AD patients (NCT03625622).doi:10.1002/alz.082892Byung Woo KangAshish KumarDong-Keun SongJae-Young Ha...